regulatory compliance
| 5 min read
The Synthetic Molecule Process Innovation Phorum brings together major pharma companies, regulators, and CDMOs to build consensus on pressing challenges in small molecule manufacturing.
| 3 min read
Patient advocates warn that political momentum to reduce animal testing is outpacing the scientific validation of alternative methods.
| 3 min read
The MHRA-led sandbox will generate real-world evidence on AI tools that could improve medicines safety, reduce late-stage failures, and accelerate drug development.
| 3 min read
How automation can help ensure the safety and efficacy of advanced therapeutic products.
| 5 min read
Industry leaders at the Advanced Therapies conference outline how early collaboration, funding, and culture shape whether breakthroughs reach patients.
| 4 min read
Unexpected breakthroughs in drug manufacturing, lawsuits, regulatory updates, and more led the news this week.
| 4 min read
The FDA’s National Priority Voucher program aims to cut standard review times from potentially years to months, raising questions about safety, access, and public health impact.
| 5 min read
A new study finds that non-core and non-essential procedures may add significant burden to participants and research sites.
| 5 min read
Computational models are reshaping how therapies are discovered, tested, and optimized.
| 5 min read
Regulatory science is increasingly relying on modeling, simulation, and AI tools to accelerate drug development while maintaining safety and efficacy.
